Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Br J Cancer
; 117(4): 494-502, 2017 Aug 08.
Article
in En
| MEDLINE
| ID: mdl-28664915
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Signal Transduction
/
Antineoplastic Combined Chemotherapy Protocols
/
Neoplasms, Glandular and Epithelial
/
Proto-Oncogene Proteins c-akt
/
AMP-Activated Protein Kinases
/
TOR Serine-Threonine Kinases
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom